Skip to Main Content

Paper Details

Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases.
Cancer Med
8
2019
CLD, HCC, HbA1c, Metformin, T2D, cancer, cardiovascular or renal diseases, chronic liver diseases, hepatocellular carcinoma, insulin, men, metformin, non, patients, thiazolidinedione, type 2 diabetes
Author NameAffiliation
John G Kuhn
Susanne SchmidtUniversity of Texas Health Science Center at San Antonio (UTHSCSA)
  • 1 - 2

Datasets

Release 1.2